Edit
Eddingpharm International Holdings Limited
http://www.eddingpharm.com/Last activity: 16.01.2026
Active
Marketing oncology products in China
Employees: 1001-5000
Total raised: $24M
Founded date: 2001
Investors 3
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Forebright | forebright... |
| - | OrbiMed | orbimed.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.09.2010 | Series B | $24M | - |
Mentions in press and media 5
| Date | Title | Description |
| 16.01.2026 | POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies | GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced significant progre... |
| 01.06.2024 | Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse | BOSTON, June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, ImmuAlpaca® mouse. The IGH-VDJ genes in the mouse genome have been successfully replaced by... |
| 01.06.2024 | Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse | BOSTON, June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, ImmuAlpaca® mouse. The IGH-VDJ genes in the mouse genome have been successfully replaced by... |
| 23.04.2019 | Lilly to sell legacy antibiotics, Ceclor and Vancocin, to China-based partner in $375M deal | More than two years after Lilly partnered with specialty drugmaker Eddingpharm to exclusively distribute its decades-old antibiotics — Ceclor and Vancocin — in mainland China, the US drugmaker is offloading the lega... |
| 17.09.2010 | Eddingpharm (Cayman) Closes $24M Series B Funding | Eddingpharm (Cayman) Inc., a Shanghai and Hong Kong-based specialty pharmaceutical marketing company focused on in-licensing, marketing and distributing hospital pharmaceutical products in the China market, closed a US$24m Series B financin... |